Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Miltefosine

EU orphan designation number: EU/3/08/567   
Active ingredient: Miltefosine
Indication: Treatment of cutaneous T-cell lymphoma
Sponsor: ExperGen Drug Development GmbH
Hernalser Hauptstraße 24/16, A-1170 Wien, Österreich

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/09/2008 Centralised Orphan - Designation EMEA/OD/030/08 (2008)5450 of 22/09/2008